Genes influencing innate and acquired immunity in type 1 diabetes and latent autoimmune diabetes in adults

Annals of the New York Academy of Sciences

Volumn 1079, Issue , 2006, Pages 67-80

  Sanjeevi, Carani B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

HLA DR; KIR; LADA; MICA; T1DM

Indexed keywords

HLA ANTIGEN CLASS 1; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ACQUIRED IMMUNITY; AUTOIMMUNE DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HISTOCOMPATIBILITY GENE; HUMAN; IMMUNITY; IMMUNOGENETICS; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES IN ADULT; LATVIA; NATURAL KILLER T CELL; PREDICTION; SCREENING TEST; SWEDEN;

EID: 33845697250     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1375.010     Document Type: Conference Paper

References (76)

1. DESCHAMPS, I., C. BOITARD, J. HORS, et al. 1992. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study. Diabetologia 35: 951-957.
2. SANJEEVI, C.B., T.P. LYBRAND, M. LANDIN-OLSSON, et al. 1994. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2 positive patients with type 1 diabetes. Tissue Antigens 44: 110-119.
3. SANJEEVI, C.B., T.P. LYBRAND, C. DEWEESE, et al. 1995. Polymorphic amino acids variations in HLA-DQ are associated with systematic physical property changes and occurrence of insulin-dependent diabetes mellitus. Diabetes 44: 125-131.
4. SANJEEVI, C.B., M. LANDIN-OLSSON, I. KOCKUM, et al. 1995. Effects of the second haplotype on the association with childhood insulin-dependent diabetes mellitus. Tissue Antigens 45: 148-152.
5. SANJEEVI, C.B., P. HÖÖK, M. LANDIN-OLSSON, et al. 1996. Analysis of DR4 subtypes and their molecular properties in a population based study of Swedish childhood diabetes. Tissue Antigens 47: 275-283.
6. KOCKUM, I., C.B. SANJEEVI, S. EASTMAN, et al. 1999. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur. J. Immunogenet. 26: 361-372.
7. GRAHAM, J., I. KOCKUM, C.B. SANJEEVI, et al. 1999. Negative association between type 1 diabetes and HLA DQB1*0602- DQA1*0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group. Eur. J. Immunogenet. 26: 117-128.
8. SANJEEVI, C.B., C. DEWESSEE, T.P. LYBRAND, et al. 1997. Analysis of critical residues of DQ6 molecules associated with insulin-dependent diabetes. Tissue Antigens 50: 61-65.
9. SANJEEVI, C.B., W.A. HAGOPIAN, M. LANDIN-OLSSON, et al. 1998. Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8. Tissue Antigens 51: 281-286.
10. SANJEEVI, C.B. 2000. DQ6 mediated protection in human insulin-dependent diabetes mellitus. Hum. Immunol. 61: 148-153.
11. HAGOPIAN, W.A., C.B. SANJEEVI, I. KOCKUM, et al. 1995. Glutamate decarboxylase-, insulin- and islet cell-antibodies, and HLA typing to detect diabetes in a general population-based study of Swedish children. J. Clin. Invest. 95: 1505-1511.
12. IRVINE, W.J. et al. 1979. The value of islet cell antibody in predicting secondary failure of oral hypoglycaemic agent therapy in diabetes mellitus. J. Clin. Lab. Immunol. 2: 23-26.
13. GROOP, L.C. et al. 1986. Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 35: 237-241.
14. HAGOPIAN, W.A., A.E. KARLSEN, A. GOTTSATER, et al. 1993. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J. Clin. Invest. 91: 368-374.
15. GENOVESE, S., E. BONIFACIO, J.M. MCNALLY, et al. 1992. Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 385-388.
16. GIANANI, R., A. PUGLIESE, S. BONNER-WEIR, et al. 1992. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 41: 347-353.
17. LUDVIGSSON, J.U. et al. 1986. HLA-DR 3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes. Diabetologia 29: 207-210.
18. TUOMI, T. et al. 1999. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48: 150-157.
19. HORTON, V., I. STRATTON, G.F. BOTTAZZO, et al. 1999. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group. Diabetologia 42: 608-616.
20. SANJEEVI, C.B., G. GAMBELUNGHE, A. FALORNI, et al. 2002. Genetics of latent autoimmune diabetes in adults. Ann. N. Y. Acad. Sci. 958: 107-111.
21. BAHRAM, S., M. BRESNAHAN, D.E. GERAGHTY & T. SPIES. 1994. A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA 91: 6259-6263.
22. BAHRAM, S. 2000. MIC genes: from genetics to biology. Adv. Immunol. 76: 1-60.
23. OTA, M. et al. 1997. Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens 49: 448-454.
24. GROH, V., S. BAHRAM, S. BAUER, et al. 1996. Cell stress regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93: 12445-12450.
25. GROH, V., R. RHINEHART, J. RANDOLPH-HABECKER, et al. 2001. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2: 255-260.
26. TIENG, V., C. LE BOUGUENEC, L. DU MERLE, et al. 2002. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc. Natl. Acad. Sci. USA 99: 2977-2982.
27. YAMAMOTO, K., Y. FUJIYAMA, A. ANDOH, et al. 2001. Oxidative stress increases MICA and MICB gene expression in the human colon carcinoma cell line (CaCo-2). Biochim. Biophys. Acta 1526: 10-12.
28. WU, J. et al. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285: 730-732.
29. SALIH, H.R., H.G. RAMMENSEE & A. STEINLE. 2002. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J. Immunol. 169: 4098-4102.
30. GROH, V., J. WU, C. YEE & T. SPIES. 2002. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734-738.
31. GAMBELUNGHE, G., A. FALORNI, M. GHADERI, et al. 1999. Microsatellite polymorphism of the MHC class I chain related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 84: 3701-3707.
32. NIKITINA ZAKE, L., I. CIMDINA, I. RUMBA, et al. 2002. Major histocompatibility complex class I chain related (MIC) A gene, TNFa microsatellite alleles and TNFB alleles in juvenile idiopathic arthritis patients from Latvia. Hum. Immunol. 63: 418-423.
33. LEE, Y.J., F.Y. HUANG, C.H. WANG, et al. 2000. Polymorphism in the transmembrane region of the MICA gene and type 1 diabetes. J. Pediatr. Endocrinol. Metab. 13: 489-496.
34. KAWABATA, Y., H. IKEGAMI, Y. KAWAGUCHI, et al. 2000. Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus. Hum. Immunol. 61: 624-629.
35. PARK, Y., H. LEE, C.B. SANJEEVI & G.S. EISENBARTH. 2001. MICA polymorphism is associated with type 1 diabetes in the Korean population. Diabetes Care 24: 33-38.
36. SHTAUVERE-BRAMEUS, A., M. GHADERI, I. RUMBA & C.B. SANJEEVI. 2002. Microsatellite allele 5 of MHC class I chain-related gene a increases the risk for insulin-dependent diabetes mellitus in Latvians. Ann. N. Y. Acad. Sci. 958: 349-352.
37. SANJEEVI, C.B., A. KANUNGO, L. BERZINA, et al. 2002. Samal. MHC class I chain related gene A (MICA) alleles distinguishes malnutrition modulated diabetes (MMDM), insulin-dependent diabetes patients (IDDM) and non-insulin dependent diabetes mellitus (NIDDM) patients from Eastern India. Ann. N. Y. Acad. Sci. 958: 341-344.
38. LOHMANN, T., J. SESSLER, H.J. VERLOHREN, et al. 1997. Distinct genetic and immunological features in patients with onset of IDDM before and after age 40. Diabetes Care 20: 524-529.
39. GUPTA, M., L. NIKITINA-ZAKE, M. ZARGHAMI, et al. 2003. Association between the transmembrane region polymorphism of MHC class I chain related Gene-A and type 1 diabetes mellitus in Sweden. Hum. Immunol. 64: 553-561.
40. GAMBELUNGHE, G., M. GHADERI, C. TORTOIOLI, et al. 2001. Two distinct MICA gene markers discriminate major autoimmune diabetes types. J. Clin. Endocrinol. Metab. 86: 3754-3760.
41. TÖRN, C., M. GUPTA, L. NIKITINA ZAKE, et al. 2003. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults. Hum. Immunol. 64: 902-909.
42. VREUGDENHIL, G.R., A. GELUK, T.H. OTTENHOFF, et al. 1998. Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Diabetologia 41: 40.
43. GUPTA, M., L.N. ZAKE, M. LANDIN-OLSSON, et al. 2003. Coxsackie virus V antibodies are increased in HLA DR3-MICA5.1 positive type 1 diabetes (T1DM) patients in Linköping region in Sweden. Hum. Immunol. 64: 874-879.
44. FLODSTROM, M., A. MADAY, D. BALAKRISHNA, et al. 2002. Target cell defense prevents the development of diabetes after viral infection. Nat. Immunol. 3: 373-382.
45. BAUER, S., V. GROH, J. WU, et al. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
46. IDE, A., S.R. BABU, D.T. ROBLES, et al. 2005. Homozygosity for premature stop codon of the MHC class I chain-related gene A (MIC-A) is associated with early activation of islet auto immunity of DR3/4-DQZ/8 high risk DAISY relatives. J. Clin. Immunol. 25: 303-308.
47. REWERS, M., J.M. NORRIS, G.S. EISENBARTH, et al. 1996. Beta-cell autoantibodies in infants and toddlers without IDDM relatives: diabetes autoimmunity study in the young (DAISY). J. Autoimmun. 9: 405-410.
48. TROWSDALE, J. 2001. Genetic and functional relationships between MHC and NK receptor genes. Immunity 15: 363-374.
49. PARHAM, P. 2005. MHC class I molecules and KIRS in human history, health and survival. Nat. Rev. Immunol. 5: 201-214.
50. RAJAGOPALAN, S. & E.O. LONG. 2005. Understanding how combinations of HLA and KIR genes influence disease. J. Exp. Med. 201: 1025-1029.
51. HAREL-BELLAN, A. et al. 1986. Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6. Proc. Natl. Acad. Sci. USA 83: 5688-5692.
52. WILSON, M.J. et al. 2000. Plasticity in the organization and sequences of human KIR/ILTgene families. Proc. Natl. Acad. Sci. USA 97: 4778-4783.
53. RAJALINGAM, R. et al. 2002. Distinctive KIR and HLA diversity in a panel of north Indian Hindus. Immunogenetics 53: 1009-1019.
54. YAWATA, M. et al. 2002. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics 54: 543-550.
55. BOYINGTON, J.C. et al. 2000. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543.
56. MANDELBOIM, O. et al. 1996. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 184: 913-922.
57. PERUZZI, M. et al. 1996. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J. Exp. Med. 184: 1585-1590.
58. RAJAGOPALAN, S. & E.O. LONG. 1997. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185: 1523-1528.
59. BOYINGTON, J.C. & P.D. SUN. 2002. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol. Immunol. 38: 1007-1021.
60. WITT, C.S. et al. 2002. Alleles of the KIR2DL4 receptor and their lack of association with preeclampsia. Eur. J. Immunol. 32: 18-29.
61. MOODIE, S.J. et al. 2002. Analysis of candidate genes on chromosome 19 in coeliac disease: an association study of the KIR and LILR gene clusters. Eur. J. Immunogenet. 29: 287-291.
62. MARTIN, M.P. et al. 2002. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J. Immunol. 169: 2818-2822.
63. NIKITINA-ZAKE, L., R. RAJALINGHAM, I. RUMBA & C.B. SANJEEVI. 2004. Killer-cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls. Ann. N. Y. Acad. Sci. 1037: 161-169.
64. VAN DER SLIK, A.R. et al. 2003. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 52: 2639-2642.
65. YEN, J.H. et al. 2001. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J. Exp. Med. 193: 1159-1167.
66. LANG, K.S., RECHER, M., T. JUNT, et al. 2005. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med., 11: 138-145.
67. ALEXOPOLOU, L., A.C. HOLT, R. MEDZHITOV & R.A. FLAVELL. 2001. Recognition of double-stranded RNA and activation of NF-kB by Toll-like receptor3. Nature 413: 732-738.
68. HEIL, F. et al. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529.
69. HEMMI, H. et al. 2000. A toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
70. POLTORAK, A. et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
71. MEAGHER, C. et al. 2003. Cytokines and chemokines in the pathogenesis of type 1 diabetes. Adv. Exp. Med. Biol. 520: 133-158.
72. WEN, L., J. PENG, Z. LI & S.F. WONG. 2004. The effect of innate immunity on autoimmune diabetes and expression of TLR on pancreatic islets. J. Immunol. 172: 3173-3180.
73. ZAKE, L.N., M. GHADERI, Y.S. PARK, et al. 2002. MHC class I chain-related gene alleles 5 and 5.1 are transmitted more frequently to type 1 diabetes offspring in HBDI families. Ann. N. Y. Acad. Sci. 958: 309-311.
74. GAMBELUNGHE, G., M. GHADERI, A. COSENTINO, et al. 2000. Association of MHC Class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia 43: 507-514.
75. BILBAO, R., A. MARTIN-PAGOLA & B. CALVO. 2001. Contribution of MICA polymorphism to type I diabetes in Basques. Diabetes Metab. Res. Rev. 17(Suppl 1):27.
76. TICA, V., L. NIKITINA-ZAKE, E. DONADI & C.B. SANJEEVI. 2003. MIC-A genotypes 4/5.1 and 9/9 are positively associated with type 1 diabetes mellitus in Brazilian population. Ann. N. Y. Acad. Sci. 1005: 310-313.